<DOC>
	<DOCNO>NCT00206752</DOCNO>
	<brief_summary>The purpose study assess feasibility avoid opposite side neck radiation therapy patient clearly one side squamous cell cancer head neck . We aim assess reduction treatment volume ( amount radiation therapy require ) , resultant xerostomia mucositis , delivery unilateral neck radiation therapy .</brief_summary>
	<brief_title>Study Unilateral Neck Irradiation Patients With SCC Head Neck</brief_title>
	<detailed_description>Patients treat definitive external beam radiation plus/minus chemotherapy plus/minus neck dissection ipsilateral neck ( post radiation ) . The primary site treat definitive radiation therapy , definitive surgery plus post-operative radiation therapy . Primary endpoint loco-regional control , well quality life , xerostomia , mucositis , neck fibrosis . Salivary evaluation shall perform prior initiation radiation therapy , second week EBRT , completion radiation . Evaluations also conduct 3 , 6 , 12 month completion EBRT . Oral mucositis assess prior initiation EBRT weekly EBRT . Evaluations also conduct 3 6 month completion EBRT . Two standardized mucositis scale use : RTOG scale WHO scale . Clinical response evaluate physical exam PET/CT . PET/CT scan do 3 , 6 , 12 , 18 , 24 month , clinically indicate follow-up .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<criteria>Squamous cell carcinoma oral cavity oropharynx , primary lesion &gt; 1 cm midline . Patient clinical radiologic evidence contralateral neck node metastasis . No evidence distant metastasis . No previous history radiation therapy chemotherapy performance status 02 Age &gt; = 18 Signed inform consent Patients must accessible treatment followup HIV positive patient Pregnancy patient practice contraception Active tobacco alcohol addiction ( assessed medical caregiver ) Serious comorbid disease prevents delivery full treatment include psychiatric disorder , cardiopulmonary disease , etc . Concomitant use trial anticancer therapeutic within 30 day entry Uncontrolled hypertension Known hypersensitivity mammalian cellderived product</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>